STS/ACC TVT Registry Launched
STS National Database News, December 2011 -- With the recent FDA approval of transcatheter valve therapy (TVT), STS and the American College of Cardiology Foundation (ACCF) have launched a new clinical data collection tool, the STS/ACC TVT Registry™, developed to track patient safety and real-world outcomes related to new TVT procedures. Created by STS and ACCF and live as of Dec. 1, the TVT Registry is designed to monitor the safety and efficacy of the newly introduced transcatheter aortic valve replacement (TAVR) procedure for the treatment of aortic stenosis in inoperable patients.
Through the capture and reporting of patient demographics, procedure details, and facility and physician information, the TVT Registry will provide a data repository capable of delivery insights into clinical practice patterns and patient outcomes.
Backed by the registry expertise of the ACCF’s NCDR and the STS National Database, the TVT Registry serves as the main repository for clinical data related to TAVR. Analysis of these data will allow the cardiovascular profession and medical community to understand how this new technology will be deployed throughout the U.S., and what impact it will have on patient outcomes as it becomes more prevalent. Data from the TVT Registry will also assist the medical device industry and the FDA in surveillance of the quality, safety, and efficacy of new medical devices.